Tilray CEO: Opportunities in scientific cannabis are spacious
Tilray’s stock is up this day, but composed down 80 p.c from a February excessive. CNBC’s Frank Holland experiences on his conversation with Tilray CEO Irwin Simon regarding the firm’s…
Read more »